Deargen Company
Deargen is an organization that specializes in AI-based genome analysis services. They are focused on advancing the treatment of rare and intractable diseases through the integration of AI and collective intelligence. Their main goals include discovering new disease targets, designing small molecules for new drugs, and realizing precision medicine. Deargen's AI technology is being applied to various new drug development treatment strategies. They have achieved collaborations with KMEDIhub, Serengen, and JW Pharmaceutical, and their deep learning technology platform, Dr. UG, is used for developing new drugs.
.png)
Headquarters:
Daejeon, South Korea
Industry:
Early Drug Development
Number Of Exists:
N/A
Employee Number:
11-50
Founded Date:
2016